Australia's most trusted
source of pharma news
Thursday, 19 February 2026
Posted 18 June 2018
Medicines Australia has joined forces with a new consortium aimed at revamping clinical trials across the country and named its representative.
CT:IQ was launched last May by health minister Greg Hunt to "develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of healthcare interventions in Australia".

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.